This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Anafi M, Gazit A, Zehavi A, Ben-Neriah Y, Levitzki A . 1993 Blood 82: 3524–3529
Beran M, Cao X, Estrov Z, Jeha S, Jin G, O'Brien S, Talpaz M, Arlinghaus RB, Lydon NB, Kantarjian H . 1998 Clin. Cancer Res. 4: 1661–1672
Boutin JA . 1994 Int. J. Biochem. 26: 1203–1226
Branford S, Rudzki Z, Walsh S, Grigg A, Arthur C, Taylor K, Herrmann R, Lynch KP, Hughes TP . 2002 Blood 99: 3472–3475
Buchdunger E, Matter A, Druker BJ . 2001 Biochim. Biophys. Acta 1551: M11–18
Carroll M, Ohno-Jones S, Tamura S, Buchdunger E, Zimmermann J, Lydon NB, Gilliland DG, Druker BJ . 1997 Blood 90: 4947–4952
Casnellie JE . 1991 Adv. Pharmacol. 22: 167–205
Chang C-J, Geahlen RL . 1992 J. Natural Products 55: 1529–1560
Corbin AS, Buchdunger E, Pascal F, Druker BJ . 2002 J. Biol. Chem. 277: 32214–32219
Corbin AS, Toledo LM, Lydon NB, Buchdunger E, Kuriyan J, Druker BJ . 2000 Blood 96: 470a
Deininger MW, Goldman JM, Lydon N, Melo JV . 1997 Blood 90: 3691–3698
Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, Heinrich MC, Tuveson DA, Singer S, Janicek M, Fletcher JA, Silverman SG, Silberman SL, Capdeville R, Kiese B, Peng B, Dimitrijevic S, Druker BJ, Corless C, Fletcher CD, Joensuu H . 2002 N. Engl. J. Med. 347: 472–480
Dolci S, Williams DE, Ernst MK, Resnick JL, Brannan CI, Lock LF, Lyman SD, Boswell HS, Donovan PJ . 1991 Nat. Genetics 352: 809–811
Dorsey JF, Jove R, Kraker AJ, Wu J . 2000 Cancer Res. 60: 3127–3131
Druker BJ, for the IRIS (International Randomized IFN vs STI571) Study Group . 2002 Proc. Am. Soc. Clin. Onc. 21: 1a
Druker BJ, Lydon NB . 2000 J. Clin. Invest. 105: 3–7
Druker BJ, Sawyers CL, Kantarjian H, Resta DJ, Fernandes Reese S, Ford JM, Capdeville R, Talpaz M . 2001a N. Engl. J. Med. 344: 1038–1042
Druker BJ, Talpaz M, Resta D, Peng B, Buchdunger E, Ford JM, Lydon NB, Kantarjian H, Capdeville R, Ohno-Jones S, Sawyers CL . 2001b N. Engl. J. Med. 344: 1031–1037
Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S, Zimmermann J, Lydon NB . 1996 Nature Med. 2: 561–566
Gambacorti-Passerini C, le Coutre P, Mologni L, Fanelli M, Bertazzoli C, Marchesi E, Di Nicola M, Biondi A, Corneo GM, Belotti D, Pogliani E, Lydon NB . 1997 Blood Cells Mol. Dis. 23: 380–394
Gorre ME, Mohammed M, Ellwood K, Hsu N, Paquette R, Rao PN, Sawyers CL . 2001 Science 293: 876–880
Graham SM, Jorgensen HG, Allan E, Pearson C, Alcorn MJ, Richmond L, Holyoake TL . 2002 Blood 99: 319–325
Hochhaus A, Kreil S, Corbin AS, La Rosée P, Müller MC, Lahaye T, Hanfstein B, Schoch C, Cross NCP, Berger U, Gschaidmeier H, Druker BJ, Hehlmann R . 2002 Leukemia in press
Hofmann WK, Jones LC, Lemp NA, de Vos S, Gschaidmeier H, Hoelzer D, Ottmann OG, Koeffler HP . 2001 Blood 99: 1860–1862
Holtz MS, Slovak ML, Zhang F, Sawyers CL, Forman SJ, Bhatia R . 2002 Blood 99: 3792–3800
Honma Y, Okabe KJ, Hozumi M, Uehara Y, Mizuno S . 1989 Cancer Res. 49: 331–334
Honma Y, Okabe-Kado J, Kasukabe T, Hozumi M, Umezawa K . 1990 Japanese J. Cancer Res. 81: 1132–1136
Hoover RR, Mahon FX, Melo JV, Daley GQ . 2002 Blood 100: 1068–1071
Kantarjian H, Sawyers C, Hochhaus A, Guilhot F, Schiffer C, Gambacorti-Passerini C, Niederwieser D, Resta D, Capdeville R, Zoellner U, Talpaz M, Druker B . 2002 New Engl. J. Med. 346: 645–652
Kasper B, Fruehauf S, Schiedlmeier B, Buchdunger E, Ho AD, Zeller WJ . 1999 Cancer Chemother. Pharmacol. 44: 433–438
Kaur G, Gazit A, Levitzki A, Stowe E, Cooney DA, Sausville EA . 1994 Anti-Cancer Drugs 5: 213–222
Kawada M, Tawara J, Tsuji T, Honma Y, Hozumi M, Wang JY, Umezawa K . 1993 Drugs Under Exp. and Clin. Res. 19: 235–241
La Rosee P, Johnson K, O'Dwyer ME, Druker BJ . 2002 Exp. Hematol. 30: 729–737
le Coutre P, Mologni L, Cleris L, Marchesi E, Buchdunger E, Giardini R, Formelli F, Gambacorti-Passerini C . 1999 J. Natl. Cancer Inst. 91: 163–168
Lugo TG, Pendergast AM, Muller AJ, Witte ON . 1990 Science 247: 1079–1082
Marley SB, Deininger MW, Davidson RJ, Goldman JM, Gordon MY . 2000 Exp. Hematol. 28: 551–557
Mow BM, Chandra J, Svingen PA, Hallgren CG, Weisberg E, Kottke TJ, Narayanan VL, Litzow MR, Griffin JD, Sausville EA, Tefferi A, Kaufmann SH . 2002 Blood 99: 664–671
Nichols GL, Raines MA, Vera JC, Lacomis L, Tempst P, Golde DW . 1994 Blood 84: 2912–2918
Oda T, Heaney C, Hagopian J, Okuda K, Griffin JD, Druker BJ . 1994 J. Biol. Chem. 269: 22925–22928
Okuda K, Weisberg E, Gilliland DG, Griffin JD . 2001 Blood 97: 2440–2448
Ottmann OG, Druker BJ, Sawyers CL, Goldman JM, Reiffers J, Silver RT, Tura S, Fischer T, Deininger MW, Schiffer CA, Baccarani M, Gratwohl A, Hochhaus A, Hoelzer D, Fernandes-Reese S, Gathmann I, Capdeville R, O'Brien S . 2002 Blood 100: 1965–1971
Peng B, Hayes M, Racine-Poon A, Druker BJ, Talpaz M, Sawyers CL, Resta D, Ford JM, Lloyd P, Capdeville R . 2001 Proc. Am. Soc. Clin. Oncol. 20: 280a
Porosnicu M, Nimmanapalli R, Nguyen D, Worthington E, Perkins C, Bhalla KN . 2001 Leukemia 15: 772–778
Roche-Lestienne C, Soenen-Cornu V, Grardel-Duflos N, Lai JL, Philippe N, Facon T, Fenaux P, Preudhomme C . 2002 Blood 100: 1014–1018
Russell ES . 1979 Adv. Genet. 20: 357–359
Sawyers CL, Hochhaus A, Feldman E, Goldman JM, Miller CB, Ottmann OG, Schiffer CA, Talpaz M, Guilhot F, Deininger MWN, Fischer T, O'Brien SG, Stone RM, Gambacorti-Passerini CB, Russell NH, Reiffers JJ, Shea TC, Chapuis B, Coutre S, Tura S, Morra E, Larson RA, Saven A, Peschel C, Gratwohl A, Mandelli F, Ben-Am M, Gathmann I, Capdeville R, Paquette RL, Druker BJ . 2002 Blood 99: 3530–3539
Schindler T, Bornmann W, Pellicena P, Miller WT, Clarkson B, Kuriyan J . 2000 Science 289: 1938–1942
Schwartzberg PL, Stall AM, Hardin JD, Bowdish KS, Humaran T, Boast S, Harbison ML, Robertson EJ, Goff SP . 1991 Cell 65: 1165–1175
Senechal K, Heaney C, Druker B, Sawyers C . 1998 Mol. Cell. Biol. 18: 5082–5090
Shah NP, Nicoll JM, Nagar B, Gorre ME, Paquette RL, Kuriyan J, Sawyers CL . 2002 Cancer Cell 2: 117–125
Soriano P . 1994 Genes Dev. 8: 1888–1896
Soriano P . 1997 Development 124: 2691–2700
Sun X, Layton JE, Elefanty A, Lieschke GJ . 2001 Blood 97: 2008–2015
Talpaz M, Silver RT, Druker BJ, Goldman JM, Gambacorti-Passerini C, Guilhot F, Schiffer CA, Fischer T, Deininger MWN, Lennard AL, Hochhaus A, Ottmann OG, Gratwohl A, Baccarani M, Stone R, Tura S, Mahon F-X, Fernandes-Reese S, Gathmann I, Capdeville R, Kantarjian HM, Sawyers CL . 2002 Blood 99: 1928–1937
ten Hoeve J, Arlinghaus RB, Guo JQ, Heisterkamp N . 1994 Blood 84: 1731–1736
Topaly J, Schad M, Zeller WJ, Ho AD, Fruehauf S . 2001 Blood 98: 617a
Tybulewicz VL, Crawford CE, Jackson PK, Bronson RT, Mulligan RC . 1991 Cell 65: 1153–1163
von Bubnoff N, Schneller F, Peschel C, Duyster J . 2002 Lancet 359: 487–491
Yaish P, Gazit A, Gilon C, Levitzki A . 1988 Science 242: 933–935
Acknowledgements
Dr Druker is supported by grants from the National Cancer Institute, The Leukemia and Lymphoma Society, Burroughs Wellcome Fund, T.J. Martell Foundation, and the Doris Duke Charitable Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Druker, B. Inhibition of the Bcr-Abl tyrosine kinase as a therapeutic strategy for CML. Oncogene 21, 8541–8546 (2002). https://doi.org/10.1038/sj.onc.1206081
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206081
Keywords
This article is cited by
-
Design, synthesis, and anticancer activity of novel 4-thiazolidinone-phenylaminopyrimidine hybrids
Molecular Diversity (2021)
-
Repositioning antispasmodic drug Papaverine for the treatment of chronic myeloid leukemia
Pharmacological Reports (2021)
-
Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site
Leukemia (2017)
-
Hepatic stellate cells: central modulators of hepatic carcinogenesis
BMC Gastroenterology (2015)
-
Imagine a world without cancer
BMC Cancer (2014)